Fetal hemoglobin per erythrocyte ( <scp>HbF</scp> /F‐cell) after gene therapy for sickle cell anemia-Reference-Cited by-同舟云学术

Fetal hemoglobin per erythrocyte ( HbF /F‐cell) after gene therapy for sickle cell anemia

Published:2022-11-30 Issue:2 Volume:98 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Sebastiani Paola¹^ORCID,Steinberg Martin H²^ORCID

Affiliation:

1. Institute for Clinical Research and Health Policy Studies, Center for Quantitative Methods and Data Science Tufts Medical Center and Tufts University School of Medicine Boston Massachusetts USA

2. Department of Medicine, Division of Hematology and Medical Oncology Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center Boston Massachusetts USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26791

Reference22 articles.

1. Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

2. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

3. Post-Transcriptional Genetic Silencing ofBCL11Ato Treat Sickle Cell Disease

4. Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: Parisian Prospective Study on Sickle Cell Disease

5. Hemoglobin S gelation and sickle cell disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Base Editors-Mediated Gene Therapy in Hematopoietic Stem Cells for Hematologic Diseases;Stem Cell Reviews and Reports;2024-04-22

2. An integrated therapeutic approach to sickle cell disease management beyond infancy;American Journal of Hematology;2023-05-12

3. Cell-based Genetic Therapy for the Induction of Foetal Haemoglobin in Sickle Cell Disease and Transfusion-dependent β-thalassaemia;Oncology & Haematology;2023